# Pharma Two B

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pharma-two-b

- Industry: Pharmaceuticals
- Headquarters: Rehovot, Israel
- Website: www.pharma2b.com
- Total disclosed funding: $38M
- Latest round: Series C (Feb 27, 2017)
- Investors on record: 5

## About

Founded in 2007 and based in Rehovot, Israel, Pharma Two B Ltd. (Pharma2b) operates as a clinical-stage pharmaceutical company focusing on the development of treatments for Parkinson’s diseases. In February 2017, Pharma Two B raised USD 30 million series C funding from Israel Biotech Fund and aMoon Partners and JVC, the funds raised will be used to complete the final pivotal phase III clinical trial needed to register P2B001.

## Funding rounds

- Series C, Feb 27, 2017, $30M — JK&B Capital, JVC, Generali Financial Holdings, Israel Biotech Fund, aMoon
- Series B, Oct 22, 2012, $8M — JK&B Capital

## Investors

- JK&B Capital (https://capitalatlas.ai/funds/jk-b-capital) — Series B, Series C
- JVC — Series C
- Generali Financial Holdings — Series C
- Israel Biotech Fund (https://capitalatlas.ai/funds/israel-biotech-fund) — Series C
- aMoon (https://capitalatlas.ai/funds/amoon) — Series C